OHSU Funding Alerts: Week of January 13, 2022

Each week, OHSU Research Development compiles a list of funding opportunities from internal sources, the government and private foundations. We publish the list here every Thursday. A pdf of the list is also available.

Featured Opportunities 
Cancer V Foundation Pediatric Translational and V Scholar Cancer Research Grant Program
What: 
Two programs to support pediatric cancer research; Translational Awards support projects that move a novel strategy from the laboratory into a human clinical trial or use specimens from a clinical trial to develop biomarkers or mechanisms and V Scholar Awards support projects either laboratory-based discovery research or translational research
Who should apply: Pediatric cancer researchers; eligibility requirements for each award are different and detailed, so see CAP listing for more details

Award: For Translational: Up to $600,000/up to three years; For V Scholar: Up to $200,000/up to two years

Deadline: Internal submission due: Jan. 26, 2022; Nomination due: Feb. 15, 2022, 2 p.m. PT
Apply through the CAP
This organization is on the President’s List; submit a notice of intent form before applying


Cancer OHSU Knight Cancer Institute Prostate Cancer Spore
What: 
Competitive renewal for KCI’s Pacific Northwest Prostate Cancer Specialized Program of Research Excellence funded by the NIH; the SPORE will likely submit four major projects and include two to four support cores, and it is anticipated that a subset of the four projects will be continuation projects and a subset will be entirely new projects 
How to apply: 
Submissions are a one-page proposal, and the template is linked in this OHSU Now post
Who should apply: Investigators with an interest in prostate cancer research
Award: Estimated to be $200,000 per year
Deadline: Jan. 30, 2022
Contact Tom Beer, M.D., professor and deputy director of the Knight Cancer Institute, if you are thinking about submitting a proposal


Cancer Pediatric Cancer Research Foundation Research Grants
What: 
Supports childhood cancer research through four grants: Basic Science Research Grants, Translational Research Grants, Emerging Investigator Fellowship Grants, and Designated Grant Programs
Who should apply: Basic and Translational grant applicants must have a PhD or MD and Emerging Investigator grant applicants must have either completed two years of their fellowship or had a position as junior faculty instructor or assistant professor for up to two years from the start of the award period
Award: For Basic: Up to $750,000/up to three years; For Translational: Up to $200,000/up to two years; For Emerging Investigator: Up to $50,000/one year; For Designated: Not listed
Deadline: Internal submission due: Feb. 4, 2022; LOI due: March 1, 2022, 5 p.m. PT; Application due: June 1, 2022, 5 p.m. PT
Apply through the CAP


Multidisciplinary Josiah Macy Jr. Foundation Board Grants and President’s Grants
What: 
Supports educational projects that improve health by advancing the education and training of future health professionals through two grant mechanisms: Board Grants and President’s Grants 
How to apply:
When you submit your application through the CAP, you must also submit a Notice of Intent form to the OHSU Foundation; the Foundation will be pleased to provide guidance and editorial review (non-scientist, funder perspective) on your application
Who should apply: Applicants to either grant type must meet OHSU Principal Investigator requirements
Award: For Board Grants: Up to $300,000/up to three years; For President’s Grants: Up to $25,000/one year
Deadline: Internal submission due: March 1, 2022; Proposals due: Rolling
Apply through the CAP
This organization is on the President’s List; submit a notice of intent form before applying

MultidisciplinaryNIGMS and ORIP High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed) and Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)
What: 
Supports groups of NIH-supported investigators to purchase or upgrade a single item of high-end, specialized, commercially available instruments or integrated systems 
How to apply:
OHSU is not limited in the number of applications we may submit, provided that the applications are for different types of equipment; however, internal review is required. You must submit a 1-3 page preliminary proposal that names a minimum of three major users who are PIs on active NIH research grants; additional information on proposal in CAP
Who should apply: PIs do not need to have an NIH research grant or any other research support but are expected to be an expert on the requested instrument and may be a core director or tenured or non-tenured faculty member; multiple PIs are not allowed
Award: For Shared Grants: Between $50,000 and $600,000/one year; For High-End Grants: Between $600,001 and $2 million/one year
Deadline: Internal submission due: March 28, 2022; Application due: June 1, 2022, 5 p.m. PT
Apply through the CAP

Internal Opportunities 

Multidisciplinary ‖ OHSU PMedIC Innovation Grant
What: Funding for collaborative projects between researchers at OHSU and Pacific Northwest National Laboratory (PNNL); proposed projects should utilize special capabilities of PNNL that are not accessible at OHSU and be innovative and generate preliminary data that will lead to a successful joint OHSU/PNNL grant application in the R, U or P series or equivalent
Who should apply: OHSU faculty with appointments in the professorial or research series; instructional, clinical and adjunct faculty and trainees are not eligible
Award: Up to $50,000/up to one year
Deadline: Jan. 14, 2022, midnight PT
Apply through the CAP; contact Laura Erker or Elizabeth Sturgill for application assistance

Trauma Trunkey Center Research and Innovation Awards
What: Supports progress on clearly articulated, early-phase research and innovation projects by providing opportunities for pilot testing, preliminary data collection, prototype development, feasibility or needs assessments or similar activities
Who should apply: Teams of faculty, staff, and students/residents either from or outside OHSU; each project team must include at least one OHSU member who serves at PI or Co-PI
Award: Between $5,000 and $20,000/up to two years
Deadline: Jan. 14, 2022, midnight PT
Apply through the CAP

MultidisciplinaryOHSU Collaborations and Entrepreneurship and OHSU Technology Transfer IDEA Gap Funding
What: Funding for developing technologies to help bridge the early-stage funding gap often experienced by innovators when moving through the commercialization process
Who should apply: All employees and students of OHSU; if either human subjects or animals are included in the project scope of work, the applicant must meet OHSU Principal Investigator requirements and non-faculty applicants must submit written approval from their supervisor or department head authorizing effort on the grant including the specific amount
Award: Up to $40,000/typically one year   
Deadline: Jan. 24, 2022
To apply, contact Jonathan Jubera to schedule a consultation to determine eligibility; further instructions in RFA 

New this week!
Cancer
OHSU Knight Cancer Institute Prostate Cancer Spore
What: Competitive renewal for KCI’s Pacific Northwest Prostate Cancer Specialized Program of Research Excellence funded by the NIH; the SPORE will likely submit four major projects and include two to four support cores, and it is anticipated that a subset of the four projects will be continuation projects and a subset will be entirely new projects
How to apply: Submissions are a one-page proposal, and the template is linked in this OHSU Now post
Who should apply: Investigators with an interest in prostate cancer research
Award: Estimated to be $200,000 per year   
Deadline: Jan. 30, 2022
Contact Tom Beer, M.D., professor and deputy director of the Knight Cancer Institute, if you are thinking about submitting a proposal 

Pediatrics OHSU Doernbecher Children’s Hospital 2022 Friends of Doernbecher Grant Program
What: Supports clinical and research projects and programs at OHSU Doernbecher Children’s Hospital; pediatric-related research projects and programs that impact children’s health are supported by the program
Who should apply: OHSU and Doernbecher faculty, clinical and research staff, graduate students, medical students, fellows and postdoctoral fellows
Award: Up to $50,000/one year
Deadline: Feb. 18, 2022, 5 p.m. PT
Apply through the CAP 

Cancer BRIDGE-C2 Center Small Grants Program
What: Small grants program held through the BRIDGE-C2 Center, an NCI-funded Implementation Science Center for Cancer Control, that aims to conduct rapid-cycle research aimed at eliminating longstanding gaps in cancer screening and prevention
Who should apply: Faculty, project scientists, research trainees, postdoctoral fellows and community practitioners at OHSU and OCHIN Inc.
Award: Up to $20,000/six months
Deadline: LOI due: March 1, 2022, 5 p.m. PT; Application due: June 15, 2022, 5 p.m. PT
Submit an LOI; send any questions about this opportunity to Sara McCrimmon

Multidisciplinary NIGMS, OHSU Research & Innovation and Vollum Institute OHSU Postbaccalaureate Research Education Program (PREP)
What: Program for recruiting and retaining Persons Excluded because of their Ethnicity or Race (PEER) postbacs for an intensive, mentored experience research experience with the goal to prepare them for pursuing a graduate degree in biomedical research
Who should apply: Researchers who have graduated or are in the process of graduating with a baccalaureate degree in a biomedically relevant science from an accredited college or university after June 1st, 2019, are US citizens, nationals or permanent residents, are not currently enrolled in a degree program and belong to a group considered to be underrepresented in the field of biomedical research; see more details
Award: Competitive research assistant salary and health benefits/one year
Deadline: March 1, 2022, 11:59 p.m. PT
Send questions to
PREPtograd@ohsu.edu
Apply through the CAP

Multidisciplinary Alliance for Visible Diversity in Science Elevate Award
What: Recognizes a member of the Oregon Health & Science University community for making effective strides in racial equity and inclusion
Who should apply: Individuals who have catalyzed positive change in cultivating a more equitable and inclusive environment within the research community; self-nominations welcome and all OHSU members can nominate
Award: $500
Deadline: Open now

Cancer CEDAR NIH Catalyst Funding
What: Funding designed to help scientists pursuing CEDAR relevant research address reviewer concerns and resubmit their proposals to the National Institutes of Health
Who should apply:
Applicants to NIH awards who received a score but were not funded
Award:
Up to $250,000/one year
Deadline: Applications accepted anytime

Multidisciplinary ‖ OCTRI Mobile Apps for Clinical Studies (MACS)
What: 
Funding to leverage new the REDCap functionality MyCap to create mobile apps that allow clinical study participants to report outcomes/data via a smartphone; the program aims to help fill the pipeline for BIP Digital Health by allowing PIs to conduct preliminary research and obtain user experience data
Who should apply: PIs who meet OHSU Principal Investigator requirements and want to create a mobile app for clinical or commercial purposes
Award:
Up to $5,000/typically one year
Deadline: Rolling; application will close when funding for the fiscal year is exhausted
Submit your project intake form through REDCap

Multidisciplinary OHSU Fellowship for Diversity in Research
What: Funds researchers with the goal of increasing the diversity of the community of scholars devoted to academic scientific research at OHSU
Who should apply: Investigators with postdoctoral training experience looking to establish an independent academic research career; scholars who identify as underrepresented minorities, differently-abled and more are welcomed
Award: Up to $8,000 plus a stipend
Deadline: Applications accepted anytime

Public Health OHSU-PSU School of Public Health Kickstarter Awards
What: Funding to support pre-award activities that advance the preparation of high-quality grant or contract applications
Who should apply: OHSU and PSU faculty with primary appointment in OHSU-PSU School of Public Health who have an extramural RFA or other opportunity identified
Award: Between $500 and $5,000/up to six months
Deadline: Accepted on a rolling basis through March 31, 2022
Apply through the CAP

Multidisciplinary OHSU School of Medicine Exploratory Research Seed Grants
What: Supports investigators who need to work with an OHSU core or with the Pacific Northwest National Laboratory (PNNL) to develop preliminary data for an application for extramural research support
Who should apply: School of Medicine faculty in the professorial series who have not received this award within the last year
Award: Up to $5,000/one year
Deadline: Applications accepted anytime
Apply through the CAP

Limited Submission Opportunities   

New this week!
Cancer
V Foundation Pediatric Translational and V Scholar Cancer Research Grant Program
What: Two programs to support pediatric cancer research; Translational Awards support projects that move a novel strategy from the laboratory into a human clinical trial or use specimens from a clinical trial to develop biomarkers or mechanisms and V Scholar Awards support projects either laboratory-based discovery research or translational research
Who should apply: Pediatric cancer researchers; eligibility requirements for each award are different and detailed, so see CAP listing for more details
Award: For Translational: Up to $600,000/up to three years; For V Scholar: Up to $200,000/up to two years
Deadline: Internal submission due:
Jan. 26, 2022; Nomination due: Feb. 15, 2022, 2 p.m. PT
Apply through the CAP
This organization is on the President’s List; submit a notice of intent form before applying 

MultidisciplinaryAssociation of American Medical Colleges Herbert W. Nickens Faculty Fellowship
What: Supports junior faculty members who demonstrate leadership potential in addressing inequity in medical education and health care
Who should apply: Full-time assistant professors who have held their position from no earlier than July 1, 2019 and have received only one appointment as assistant professor
Award: $25,000/one year 
Deadline: Internal submission due:
Feb. 1, 2022; Application due: April 1, 2022, 8:59 p.m. PT
Apply through the CAP

New this week!
Cancer
Pediatric Cancer Research Foundation Research Grants
What: Supports childhood cancer research through four grants: Basic Science Research Grants, Translational Research Grants, Emerging Investigator Fellowship Grants, and Designated Grant Programs
Who should apply: Basic and Translational grant applicants must have a PhD or MD and Emerging Investigator grant applicants must have either completed two years of their fellowship or had a position as junior faculty instructor or assistant professor for up to two years from the start of the award period
Award: For Basic: Up to $750,000/up to three years; For Translational: Up to $200,000/up to two years; For Emerging Investigator: Up to $50,000/one year; For Designated: Not listed
Deadline: Internal submission due:
Feb. 4, 2022; LOI due: March 1, 2022, 5 p.m. PT; Application due: June 1, 2022, 5 p.m. PT
Apply through the CAP

New this week!
Aging
NIA Coordinating Center for the Claude D. Pepper Older Americans Independence Centers (OAICs) (U24 Clinical Trial Optional)
What: Coordinating Center for the Claude D. Pepper Older Americans Independence Centers program that will be a facilitator for OAIC site interactions and a conduit for translating OAIC objectives and findings to both scientific and general audiences
Who should apply: Anyone with a research interest in maintaining or restoring independence in older persons
Award: Up to $2.125 million/up to five years
Deadline: Internal submission due:
Feb. 24, 2022; LOI due: April 16, 2022 (LOI not required but highly encouraged); Application due: May 16, 2022, 5 p.m. PT
Apply through the CAP

New this week!
Multidisciplinary
Josiah Macy Jr. Foundation Board Grants and President’s Grants
What: Supports educational projects that improve health by advancing the education and training of future health professionals through two grant mechanisms: Board Grants and President’s Grants
How to apply: When you submit your application through the CAP, you must also submit a Notice of Intent form to the OHSU Foundation; the Foundation will be pleased to provide guidance and editorial review (non-scientist, funder perspective) on your application
Who should apply: Applicants to either grant type must meet OHSU Principal Investigator requirements
Award: For Board Grants: Up to $300,000/up to three years; For President’s Grants: Up to $25,000/one year  
Deadline: Internal submission due:
March 1, 2022; Proposals due: Rolling
Apply through the CAP
This organization is on the President’s List; submit a notice of intent form before applying

Allergic Disease NIAID Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional)
What: Supports centers that integrate clinical and translational research to conduct studies on the mechanisms underlying the onset and progression of diseases of interest including asthma, rhinitis (allergic and non-allergic), chronic rhinosinusitis, atopic dermatitis, food allergy and drug allergy
Who should apply: Anyone with a research interest in asthma and allergic diseases, though multiple PIs are only allowed for the Overall Program, and an investigator can serve as a PI on only one AADCRC award or application; further eligibility info in FOA
Award: Up to $4.5 million/up to five years
Deadline: Internal submission due:
March 3, 2022; LOI due: May 3, 2022 (LOI not required but highly encouraged); Application due: June 3, 2022, 5 p.m. PT
Apply through the CAP

New this week!
Multidisciplinary
NIGMS and ORIP High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed) and Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)
What: Supports groups of NIH-supported investigators to purchase or upgrade a single item of high-end, specialized, commercially available instruments or integrated systems
How to apply: OHSU is not limited in the number of applications we may submit, provided that the applications are for different types of equipment; however, internal review is required. You must submit a 1-3 page preliminary proposal that names a minimum of three major users who are PIs on active NIH research grants; additional information on proposal in CAP
Who should apply: PIs do not need to have an NIH research grant or any other research support but are expected to be an expert on the requested instrument and may be a core director or tenured or non-tenured faculty member; multiple PIs are not allowed
Award: For Shared Grants: Between $50,000 and $600,000/one year; For High-End Grants: Between $600,001 and $2 million/one year    
Deadline: Internal submission due:
March 28, 2022; Application due: June 1, 2022, 5 p.m. PT
Apply through the CAP

Merit Prizes and Awards

Multidisciplinary NOSTER and Science Microbiome Prize
What: Rewards innovative research by young investigators working on the functional attributes of the microbiota of any organism that has potential to contribute to our understanding of human or veterinary health and disease or to guide therapeutic interventions
Who should apply: Researchers younger than thirty-five who have received their degree in the last 10 years; work submitted for consideration must have been performed in the past three years
Award: $25,000
Deadline: Jan. 24, 2022

Neuroscience ‖ Brain Sciences 2022 Young Investigator Awards
What: Honors three young investigators in recognition of their excellence in the field of neuroscience
Who should apply: PhDs who will be under 35 years of age by the deadline, have produced ground-breaking research and made a significant contribution to the advancement of neuroscience and are nominated by senior scientists
Award: Approximately $1,644.46 (amount converted from Swiss Francs) 
Deadline: Jan. 31, 2022 

New this week!
Multidisciplinary
PhRMA Foundation Value Assessment Challenge Awards
What: Supports research on pressing questions related to value assessment in health care through two award mechanisms, one for health equity and one for patient-centered outcomes
Who should apply:
Anyone with a research interest in health equity or patient-centered outcomes
Award: Up to $50,000
Deadline: March 1, 2022, 8:59 p.m. PT 

Neuroscience Science & PINS Prize for Neuromodulation
What: Rewards innovative research that modulates neural activity through physical (electrical, magnetic, optical) stimulation of targeted sites in the nervous system with implications for translational medicine
Who should apply:
Investigators younger than forty-five who have received their degree in the last 10 years; work submitted for consideration must have been performed in the past three years
Award: $25,000
Deadline: March 15, 2022

Cardiology McGill 2022 Louis and Artur Lucian Award for Research in Circulatory Diseases
What: Rewards outstanding research in the field of circulatory diseases by a scientific investigator or group of investigators whose contribution to knowledge in this field is deemed worthy of special recognition
Who should apply:
Researchers whose current work is in the circulatory disease field
Award: Approximately $58,426 (amount converted from CAD)
Deadline: April 1, 2022

COVID-19 Opportunities

Due to the decline in new funding opportunities related to COVID-19, we are transitioning the separate COVID-19 Funding Alerts to this space. You can still view the archive of COVID-19 Funding Alerts, and a list of still-open opportunities will be updated weekly.

New this week!
Dentistry NIDCR Notice to Extend Eligibility for Submission of Pathway to Independence Award Applications (K99/R00) to NIDCR due to Covid-19 disruptions

Multidisciplinary Multiple NIH Organizations Notice of Special Interest (NOSI): Availability of Administrative Supplements for Research on Pathobiological Mechanisms of Post-Acute Sequelae of SARS-CoV-2 Infection
What: Funding to encourage investigators with expertise and insights germane to post-acute sequelae of SARS-CoV-2 infection (PASC) pathobiology to apply for supplemental funding that would enable them to leverage current awards to rapidly advance understanding of the pathobiological underpinnings of PASC
Who should apply: Grantees of active NIH awards
Award: Up to $1.5 million/up to two years    
Deadline: Jan. 24, 2022, 5 p.m. PT 

MultidisciplinaryMultiple NIH Organizations Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities
What: Supports research on strategies and interventions to address vaccine hesitancy, uptake and implementation among populations who experience health disparities in the US and its territories
Who should apply: Anyone with a research interest in vaccine hesitancy
Award: Dependent upon FOA you apply through        
Deadline: Open from Feb. 5, 2022 through Jan. 8, 2023 

Multidisciplinary NHLBI, NIAID and NICHD Notice of Special Interest (NOSI) Pediatric COVID-19 and Respiratory Viral Co-infection
What: Supports projects that will employ existing and new clinical trial cohorts/observational cohorts to screen for co-infection, phenotype and collect biospecimens to answer COVID-19 questions outlined in the NOSI
Who should apply: Anyone with a research interest in pediatric COVID and respiratory viral co-infection
Award: Dependent upon FOA you apply through        
Deadline: Open from Feb. 5, 2022 through Sept. 8, 2025 

Rheumatology NIAMS Notice of Special Interest: Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases
What: Announces to potential applicants to the NIAMS an interest in research on the impact of COVID-19 as related to diseases and conditions within the NIAMS mission
Who should apply: Anyone with a research interest in NIAMS-related topics and COVID-19
Award: Dependent upon FOA you apply through        
Deadline: Open from Feb. 5, 2022 through Jan. 7, 2023

NIH Federal Opportunities

This week the NIH released funding opportunities concerning translational science, instrumentation and Alzheimer’s disease. We’ve highlighted some opportunities of potential interest below.

Pain Management Multiple NIH Organizations HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)
What: Supports basic science discovery of targets in the peripheral nervous system, central nervous system, immune system or other tissues in the body that can be used to develop treatments that have minimal side effects and little to no abuse/addiction liability
Who should apply: Anyone with a research interest in safer pain treatment
Award: Not limited/up to five years    
Deadline: LOI due: Feb. 2, 2022 (LOI not required but highly encouraged); Application due: March 2, 2022, 8:59 p.m. PT

Substance Use Multiple NIH Organizations Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed)
What: Supports early and mid-career investigators who strive to expand their research trajectories in the areas of therapeutic drug, biologic or device development; this FOA is particularly interested in the development of novel treatments for pain, addiction and overdose in order to address the ongoing opioid epidemic
Who should apply: Citizens or non-citizen nationals of the United States and individuals who have been lawfully admitted for permanent residence who are early and mid-career investigators, i.e. postdoctoral fellows/associates to associate professors
Award: Salary and other program-related expenses/up to one year    
Deadline: LOI due: Feb. 3, 2022; Application due: Feb. 18, 2022, 8:59 p.m. PT

Neuroscience Multiple NIH Organizations Notice of Special Interest (NOSI): BRAIN Initiative: Translation of Groundbreaking Technologies from Early-stage Development through Early Clinical Study via Blueprint MedTech
What: Supports non-clinical validation for subsequent clinical feasibility studies and the development and translation of groundbreaking neurotechnologies that fit within the mission of the BRAIN Initiative
Who should apply: Anyone with a research interest in developing new neurotechnologies
Award: Not limited/up to five years       
Deadline: Open from Feb. 18, 2022 through June 20, 2024

NeuroscienceNIA Notice of Special Interest (NOSI): Novel Approaches to Diagnosing and Studying Clinical Alzheimer’s Disease and Related Dementias
What: Supports applications that develop and apply novel biomarkers to study the biology of Alzheimer’s disease and Alzheimer’s disease-related dementias
Who should apply: Anyone with a research interest in biomarkers and AD/ADRD
Award: Dependent upon FOA you apply through       
Deadline: Open from March 11, 2022 through Nov. 13, 2024

HIV/AIDS NIDA, NIMH and OBSSR Advancing communication strategies to support future HIV vaccine use (R01 Clinical Trial Optional) and (R21 Clinical Trial Optional)
What: Supports novel health communication research designed to inform and support acceptance and uptake of future vaccines that protect against HIV
Who should apply: Anyone with a research interest in HIV vaccines and vaccine communication
Award: For R01: Not limited/up to five years; For R21: Up to $275,000/up to two years    
Deadline: LOI due: April 10, 2022 (LOI not required but highly encouraged); Application due: May 10, 2022, 5 p.m. PT

Aging NIA Pharmacokinetic and Pharmacodynamic (PK/PD) Studies of mTOR Inhibitors on Aging-Related Indications (U01 Clinical Trial Required)
What: Supports pharmacokinetic and pharmacodynamic studies of mTOR inhibitors in populations living with different aging-related diseases or in relatively healthy older adult populations at risk for a variety of aging conditions
Who should apply: Anyone with a research interest in pharmacodynamic studies of mTOR inhibitors
Award: Not limited/up to four years    
Deadline: LOI due: April 14, 2022 (LOI not required but highly encouraged); Application due: June 15, 2022, 5 p.m. PT

Immunology NIAID Host Immunity and Novel Immunization Strategies for Clostridioides difficile Infection (CDI) (U19 Clinical Trial Not Allowed)
What: Supports the formation of Cooperative Research Centers to pursue vaccine development through multidisciplinary investigations into the host immune response to Clostridioides difficile infection
Who should apply: Anyone with a research interest in Clostridioides difficile infection
Award: Up to $5 million/up to five years    
Deadline: LOI due: April 20, 2022 (LOI not required but highly encouraged); Application due: May 20, 2022, 5 p.m. PT 

Administrative Supplements

Multidisciplinary NIGMS Notice of Special Interest (NOSI): Administrative Supplements to Support Undergraduate Summer Research Experiences

Requests for Information

NeuroscienceNINDS Request for Information: Soliciting Input on Research Priorities for Amyotrophic Lateral Sclerosis (ALS)

Private Opportunities

NeuroscienceFRAXA Research Foundation Clinical Trial Grants
What: Supports clinical research with human subjects with Fragile X, particularly trials of potentially disease-modifying agents previously validated in Fragile X animal models
Who should apply:
Researchers with an interest in Fragile X syndrome
Award: Not limited/not limited but renewed on yearly basis
Deadline: Feb. 1, 2022, 8:59 p.m. PT

Multidisciplinary Southwest National Primate Research Center Pilot Research Grants
What: Support for investigators to use SNPRC nonhuman primate resources in highly focused, short-term studies likely to enhance the value, utility, feasibility and attractiveness of nonhuman primates for biomedical research
Who should apply:
Investigators holding staff scientist (research assistant professor) through full scientist (full professor) or equivalent positions
Award: Up to $100,000/not specified
Deadline: LOI due: Feb. 4, 2022; Full proposal due: March 25, 2022

Multidisciplinary Patient-Centered Outcomes Research Institute Implementation Funding
What: Funding for patient-centered outcomes research through two different opportunities studying these topics: Implementation of effective shared decision making approaches in practice settings and implementation of findings from PCORI’s major research investments
Who should apply: Dependent upon funding opportunity
Award: Between $1.5 and $2.5 million/up to three years
Deadline: LOI due: Feb. 1, 2022, 2 p.m. PT; Full application due: April 12, 2022, 2 p.m. PT

Multidisciplinary Patient-Centered Outcomes Research Institute Research Funding
What: Funding for patient-centered outcomes research through five different opportunities in these areas: adolescent alcohol use; mental health in individuals with intellectual and developmental disabilities; delirium in older adults; broad pragmatic studies; and methods for conducting patient-centered outcomes research
Who should apply: Dependent upon funding opportunity
Award: Between $750,000 and $10 million/between three and five years
Deadline: LOI due: Feb. 8, 2022, 2 p.m. PT; Full application due: May 3, 2022, 2 p.m. PT

Psychology American Psychological Foundation Dr. Christine Blasey-Ford Grant
What: Supports research focused on the understanding, prevention and treatment of the consequences of exposure to traumatic events such as sexual assault, sexual harassment and rape
Who should apply:
Graduate students and early-career psychologists (who are at the doctoral level and no more than 10 years postdoctoral) who have a demonstrated knowledge of trauma and trauma research
Award: Up to $1,250/not specified
Deadline: Feb. 15, 2022

NeuroscienceNational Multiple Sclerosis Society Therapeutic Development Opportunities Addressing Nervous System Repair in Multiple Sclerosis
What: Supports therapeutic development efforts in the area of nervous system repair in MS such as medicinal chemistry or biologic product development optimization, proof of concept for sufficiently-characterized compounds or biologics and PK/ADMET studies
Who should apply:
For-profit commercial organizations and not-for-profit research institutions
Award: Up to $600,000/up to two years
Deadline: LOI due: Feb. 16, 2022; Full proposal due: Feb. 23, 2022

NeuroscienceNew York Stem Cell Foundation NYSCF – Robertson Neuroscience Investigator Awards
What: Supports early career investigators who are researching neuroscience, especially those whose research areas may be under-supported by traditional funding mechanisms and underrepresented in the field as a whole
Who should apply:
Neuroscience investigators who will be within six years of starting a faculty or comparable position on June 1, 2022
Award: Up to $1.5 million/up to five years
Deadline: Feb. 16, 2022, 2 p.m. PT
This organization is on the President’s List; submit a notice of intent form before applying

Allergies Johnson & Johnson Innovation Food Allergy Prevention QuickFire Challenge
What: Funding to develop novel methods, products or technologies with the potential to prevent children from developing food allergy in the early years of their life
Who should apply:
Anyone with a research interest in early childhood food allergies
Award: Up to $150,000/not specified
Deadline: Feb. 18, 2022

Cancer Alex’s Lemonade Stand Foundation Pediatric Oncology Student Training Program
What: Internships for students interested in pediatric oncology research that provide an opportunity for students to train with a pediatric oncology mentor
Who should apply:
Students must currently be enrolled in an undergraduate, graduate or medical degree-granting program, and mentors must be ALSF grantees, advisory board or review board members
Award: Up to $5,000/up to 10 weeks
Deadline: Feb. 21, 2022, 5 p.m. PT

Multidisciplinary Human Animal Bond Research Institute Addressing Evidence-Based Health Benefits of Human-Animal Interaction
What: Supports research on the health outcomes of pet ownership and/or animal-assisted activity or therapy, both for people and the animals involved
Who should apply:
Anyone with a research interest in the health benefits of human-animal interaction
Award: Up to $45,000/twenty months
Deadline: Feb. 24, 2022, 8:59 p.m. PT

Multidisciplinary Robert Wood Johnson Foundation Health Policy Research Scholars
What: National leadership development program for full-time doctoral students who want to improve health, well-being, and equity; challenge long-standing, entrenched systems; exhibit new ways of working; and collaborate across disciplines and sectors
Who should apply:
Full-time, second-year doctoral students who are from populations underrepresented in specific doctoral disciplines and/or historically marginalized backgrounds and from nonclinical, research-focused disciplines in which policy is a key driver of change
Award: Up to $120,000/up to four years
Deadline: March 16, 2022, noon PT
This organization is on the President’s List; submit a notice of intent form before applying

NeuroscienceJames S. McDonnell Foundation Opportunity Awards
What: Supports projects leading to new conceptual and empirical studies of cognition and behavior that consider the biological and experiential trajectories that contribute to ongoing cognitive and behavioral development
Who should apply:
Investigators with a research interest in cognitive and behavioral development
Award: Up to $250,000/up to four years
Deadline: April 1, 2022, 1:59 p.m. PT                                                       

Previously Published Opportunities

Federal 

January 2022

Infectious Disease NIAID Systems Biology for Infectious Diseases (U19 Clinical Trial Not Allowed) Application due: Jan. 14, 2022, 5 p.m. PT

NeuroscienceMultiple NIH Organizations BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed) LOI due: Jan. 15, 2022 (LOI not required but highly encouraged); Application due: Feb. 15, 2022, 5 p.m. PT

Cardiology NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) and Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional) LOI due: Jan. 15, 2022 (LOI not required but highly encouraged); Application due: Feb. 15, 2022, 5 p.m. PT

MultidisciplinaryNIDA High Priority HIV and Substance Use Research (R01 Clinical Trial Optional) LOI due: Jan. 15, 2022 (LOI not required but highly encouraged); Application due: Feb. 15, 2022, 5 p.m. PT

Dentistry Central Oregon Health Council Improving Coordination Between Oral Health and Primary Care Deadline: Jan. 17, 2022, 11:59 p.m. PT

Infectious Disease NIAID Advancing Group A Streptococcus Vaccine Discovery (R01 Clinical Trial Not Allowed) LOI due: Jan. 18, 2022 (LOI not required but highly encouraged); Application due: Feb. 18, 2022, 5 p.m. PT

Mental Health NIMH Enhanced Interpersonal Focused Strategies for Suicide Prevention Interventions (R34 Clinical Trial Required) LOI due: Jan. 18, 2022 (LOI not required but highly encouraged); Application due: Feb. 18, 2022, 5 p.m. PT

MultidisciplinaryNIH Common Fund Cellular Senescence Network: Technology Development and Application in Murine Systems (UG3/UH3 Clinical Trial Not Allowed) Application due: Jan. 19, 2022, 5 p.m. PT

Biology NSF Research and Mentoring for Postbaccalaureates in Biological Sciences (RaMP) Deadline: Jan. 20, 2022, 5 p.m. PT

MultidisciplinaryNHGRI and NIBIB New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research (R01 Clinical Trial Optional) LOI due: Jan. 22, 2021 (LOI not required but highly encouraged); Application due: Feb. 22, 2021, 5 p.m. PT

Neuroscience NINDS Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed) Application due: Jan. 22, 2022, 5 p.m. PT

MultidisciplinaryAHRQ and CQuIPS Large Health Services Research Demonstration and Dissemination Projects for Combating Antibiotic-Resistant Bacteria (CARB)(R18) and Large Research Projects for Combating Antibiotic-Resistant Bacteria (CARB) (R01) Deadline: R18 due: Jan. 25, 2022, 5 p.m. PT; R01 due: Feb. 5, 2022, 5 p.m. PT

Audiology NIDCD Notice of Special Interest: Expanding the Otitis Media Research Workforce: Focus on Early Stage Investigators Deadline: Open from Jan. 25, 2022 through Sept. 8, 2025

Biology NSF Dark Dimensions of the RNA Regulome (D2R2) Preliminary proposal due: Jan. 31, 2022, 5 p.m. PT; Full proposal due: Aug. 31, 2022, 5 p.m. PT

February 2022

NeuroscienceNIA Cell-Specific Impact of Liquid-Liquid Phase Separation in Aging and AD/ADRD (R21 Clinical Trial Not Allowed) LOI due: Feb. 1, 2022 (LOI not required but highly encouraged); Application due: March 3, 2022, 5 p.m. PT

Environmental Health NIEHS Virtual Consortium for Translational/Transdisciplinary Environmental Research (ViCTER) (R01 Clinical Trial Optional) Application due: Feb. 1, 2022, 5 p.m. PT

MultidisciplinaryMultiple NIH Organizations NIH HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 Clinical Trials Optional) LOI due: Feb. 2, 2022 (LOI not required but highly encouraged); Application due: March 2, 2022, 5 p.m. PT

Aging NIA Transition to Aging Research for Predoctoral Students (F99/K00 Clinical Trial Not Allowed) Deadline: Feb. 3, 2022, 5 p.m. PT

Gastroenterology NIDDK High-Resolution Exploration of the Human Islet Tissue Environment [HIRN Human Pancreas Analysis Consortium (HPAC)] (U01 – Clinical Trial Not Allowed) LOI due: Feb. 3, 2022 (LOI not required but highly encouraged); Application due: March 3, 2022, 5 p.m. PT

Endocrinology NIDDK Pilot and Feasibility Studies to Improve Technology Adoption and Reduce Health Disparities in Type 1 Diabetes Mellitus (R01 Clinical Trial Required) LOI due: Feb. 3, 2021 (LOI not required but highly encouraged); Application due: March 3, 2021, 5 p.m. PT

Endocrinology NIDDK Understanding and Targeting the Pathophysiology of Youth-onset Type 2 Diabetes – Clinical Centers (U01 Clinical Trial Not Allowed) LOI due: Feb. 3, 2022 (LOI not required but highly encouraged); Application due: March 3, 2022, 5 p.m. PT

Genomics NHGRI Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional) LOI due: Feb. 4, 2022 (LOI not required but highly encouraged); Application due: March 4, 2022, 5 p.m. PT

NeuroscienceNIA and NINDS Role of Astrocytes in Degeneration of the Neurovascular Unit in AD/ADRDs (R01 Clinical Trial Not Allowed) Deadline: Feb. 4, 2022, 5 p.m. PT

MultidisciplinaryMultiple NIH Organizations Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed) and (R21 Clinical Trials Not Allowed) R01 due: Feb. 5, 2022, 5 p.m. PT; R21 due: Feb. 16, 2022, 5 p.m. PT

MultidisciplinaryMultiple NIH Organizations Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 – Basic Experimental Studies with Humans) and (R01 Clinical Trials Not Allowed) Deadline: Clinical R01 due: Feb. 5, 2022; Basic R01 due: March 5, 2022, 5 p.m. PT

Multidisciplinary Multiple NIH Organizations Effectiveness of School-Based Health Centers to Advance Health Equity (R01 Clinical Trial Optional) Deadline: Feb. 5, 2022, 5 p.m. PT

MultidisciplinaryMultiple NIH Organizations Measures and Methods to Advance Research on Minority Health and Health Disparities-Related Constructs (R01 Clinical Trial Not Allowed) Deadline: Feb. 5, 2022, 5 p.m. PT

Multidisciplinary Multiple NIH Organizations Notice of Special Interest (NOSI): Epidemiologic studies in Asian Americans, Native Hawaiians, and Pacific Islanders (Parent R01 Clinical Trial Not Allowed) Deadline: Open from Feb. 5, 2022 through Nov. 19, 2024

MultidisciplinaryMultiple NIH Organizations Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities (R01 Clinical Trial Optional) Deadline: Feb. 5, 2022, 5 p.m. PT

CancerNCI Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) Deadline: Feb. 5, 2022, 5 p.m. PT

CancerNCI Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01 Clinical Trial Not Allowed) and (R21 Clinical Trial Not Allowed) Deadline: R01 due: Feb. 5, 2022, 5 p.m. PT; R21 due: Feb. 16, 2022, 5 p.m. PT

Cancer NCI Notice of Special Interest (NOSI): Research on Interprofessional Teamwork and Coordination During Cancer Diagnosis and Treatment Deadline: Open from Feb. 5, 2022 through Oct. 9, 2024

MultidisciplinaryNCI and NHLBI Notice of Special Interest (NOSI): Improving Outcomes in Cancer Treatment-Related Cardiotoxicity Deadline: Open from Feb. 5, 2022 through Nov. 6, 2024

Multidisciplinary NCI, NHLBI and NICHD Notice of Special Interest (NOSI): Dietary, Physical Activity, Sedentary Behavior and Sleep Assessment Methodologies Among Infants and Young Children (Birth to 5 years) through Adults Deadline: Open from Feb. 5, 2022 through May 8, 2023

Multidisciplinary NCI, NIDCR and NIMHD Notice of Special Interest (NOSI): Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities Deadline: Open from Feb. 5, 2022 through Jan. 8, 2025

Ophthalmology NEI Regenerative Medicine Clinical Trial Planning Grant (R34 – Clinical Trials Not Allowed) Deadline: Feb. 5, 2022, 5 p.m. PT

MultidisciplinaryNHLBI Notice of Special Interest (NOSI): Heart, Lung, Blood and Sleep Focused Ancillary Studies to Large Ongoing Clinical Studies (Revised) Deadline: Open from Feb. 5, 2022 through May 8, 2023

Hematology NHLBI, NIA and NIDDK Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed) Deadline: Feb. 5, 2022, 5 p.m. PT

MultidisciplinaryNHLBI, NIA and NINDS Notice of Special Interest (NOSI): Promoting research to understand vascular contributions to cognitive impairment and dementia (VCID) Deadline: Open from Feb. 5, 2022 through May 8, 2025

Neuroscience NIA Alzheimer’s Drug-Development Program (U01 Clinical Trial Optional) Application due: Feb. 5, 2022, 5 p.m. PT

NeuroscienceNIA and NINDS Prodromal Synaptic and Circuit Changes that Contribute to AD/ADRD Onset and Progression (R01 Clinical Trial Not Allowed) Deadline: Feb. 5, 2022, 5 p.m. PT

Infectious Disease NIAID Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Universal Influenza Vaccine Deadline: Open from Feb. 5, 2022 through Jan. 7, 2025

Immunology NIAID Notice of Special Interest (NOSI): Molecular and Genetic Characterization of Inborn Errors of Immunity Deadline: Open from Feb. 5, 2022 through Jan. 7, 2025

Pediatrics NICHD Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 – Clinical Trial Optional), (R03 – Clinical Trial Optional) and (R21 – Clinical Trial Optional) R01 due: Feb. 5, 2022, 5 p.m. PT; R03 and R21 due: Feb. 16, 2022, 5 p.m. PT

Pediatrics NICHD Notice of Special Interest (NOSI): Advancing Innovative Non-invasive Physiologic Monitoring To Improve Fetal Assessment Deadline: Open from Feb. 5, 2022 through May 8, 2024

Multidisciplinary NIDA and NIMH Notice of Special Interest (NOSI): Reducing Stigma Related to Drug Use in Human Service Settings Deadline: Open from Feb. 5, 2022 through Jan. 8, 2025

MultidisciplinaryNIMH Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional) and (R21 Clinical Trial Optional) Deadline: R01 due: Feb 5, 2022; R21 due: Feb. 16, 2022, 5 p.m. PT

Neuroscience NINDS Clinical Trial Readiness for Functional Neurological Disorders (U01 Clinical Trial Optional) Application due: Feb. 5, 2022, 5 p.m. PT

NeuroscienceNINDS Notice of Special Interest: Biomarker Discover and Validation in Functional Neurological Disorders Deadline: Open from Feb. 5, 2022 through Jan. 8, 2025

Ophthalmology NEI Ocular Surface Innervation from Cell Types to Circuit Functions (U01 Clinical Trial Not Allowed) LOI due: Feb. 7, 2022 (LOI not required but highly encouraged); Application due: March 7, 2022, 5 p.m. PT

Cancer NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed) Deadline: Feb. 8, 2021, 5 p.m. PT

Infectious Disease NIAID Identification and Characterization of Persistence Mechanisms of Select Protozoan Pathogens (R01 Clinical Trial Not Allowed) Application due: Feb. 8, 2022, 5 p.m. PT

Immunology NIAID Development of Microbiome-Related Approaches for Diagnosis/Mitigation/Treatment of Radiation Injuries (U01 Clinical Trial Not Allowed) Application due: Feb. 9, 2022, 5 p.m. PT

Pharmacology FDA CDER PBPK Modeling to Support an Assessment of Bioequivalence for Locally-Acting Drugs in the Gastrointestinal Tract (U01) Clinical Trial Optional LOI due: Feb. 11, 2022 (LOI not required but highly encouraged); Application due: March 31, 2022, 8:59 p.m. PT

MultidisciplinaryMultiple NIH Organizations HEAL Initiative: Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33, Clinical Trial Required) Application due: Feb. 11, 2022, 5 p.m. PT

NeuroscienceNIA and NINDS Clinical Relevance of the Linkage between Environmental Toxicant Exposures and Alzheimer’s Disease and Related Dementias (R01 Clinical Trial Not Allowed) LOI due: Feb. 11, 2022 (LOI not required but highly encouraged); Application due: March 11, 2022, 5 p.m. PT

MultidisciplinaryNIBIB and NIMHD Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional) Deadline: Feb. 11, 2022, 5 p.m. PT

MultidisciplinaryAHRQ Patient-Centered Outcomes Research (PCOR) Mentored Research Scientist Career Development Award (K01) Deadline: Feb. 12, 2022, 5 p.m. PT

Aging NIA Career Transition Award (K22 Independent Clinical Trial Not Allowed)  Deadline: Feb. 12, 2022, 5 p.m. PT

Pain Management NCCIH NIH-DOD-VA Pain Management Collaboratory – Pragmatic and/or Implementation Science Demonstration Projects ((UG3/UH3) Clinical Trial Required) LOI due: Feb. 15, 2022 (LOI not required but highly encouraged); Application due: March 15, 2022, 5 p.m. PT

MultidisciplinaryNIA and NIMH Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional) and (R21 Clinical Trial Optional) LOI due: Feb. 15, 2022 (LOI not required but highly encouraged); Application due: March 15, 2022, 5 p.m. PT

CancerNCI Notice of Special Interest (NOSI): RNA Modifications in Cancer Biology Deadline: Open from Feb. 16, 2022 through May 8, 2023

Immunology NIAID Notice of Special Interest (NOSI): Leveraging Microbial Exposure for Improving Mouse Models of Human Immunity Deadline: Open from Feb. 16, 2022 through Jan. 7, 2025

Endocrinology NIDDK Analysis, Technology, Leadership, Administration and Science (ATLAS) Center (U24 Clinical Trial Not Allowed) LOI due: Feb. 24, 2022 (LOI not required but highly encouraged); Application due: March 24, 2022, 5 p.m. PT

Pediatrics NICHD Elucidating the Role of Nutrition in Care and Development of Preterm Infants (R01 Clinical Trial Optional) LOI due: Feb. 28, 2022 (LOI not required but highly encouraged); Application due: March 30, 2022, 5 p.m. PT

MultidisciplinaryNICHD, NIDA and NIMH Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional) and Scientific Leadership Center (UM2 Clinical Trial Optional) LOI due: Feb. 28, 2022 (LOI not required but highly encouraged); Application due: March 31, 2022, 5 p.m. PT

Multidisciplinary NICHD and ORWH Promoting Reproductive Health for Adolescents and Adults with Disabilities (R01 Clinical Trial Optional) LOI due: Feb. 28, 2022 (LOI not required but highly encouraged); Application due: March 30, 2022, 5 p.m. PT

March 2022

Biology FDA Research to support the development of alternatives to antimicrobials for use in food-producing animals (U01) Clinical Trial Not Allowed LOI due: March 1, 2022 (LOI not required but highly encouraged); Application due: April 1, 2022, 8:59 p.m. PT

Neuroscience NIH Common Fund SPARC VNS Endpoints from Standardized Parameters (VESPA) (U54 Clinical Trial Required) LOI due: March 1, 2022 (LOI not required but highly encouraged); Application due: April 1, 2022, 5 p.m. PT

Substance Use Multiple NIH Organizations HEAL Initiative: Data and Methods to Address Urgent Needs to Stem the Opioid Epidemic (R01- Clinical Trial Not Allowed) Deadline: March 10, 2022, 5 p.m. PT

Neuroscience NIA and NINDS Research on Current Topics in Alzheimer’s Disease and Its Related Dementias (R01 Clinical Trial Optional) and (R21 Clinical Trial Optional) Deadline: March 11, 2022, 5 p.m. PT

Multidisciplinary NCI and ODP Center for Rapid Surveillance of Tobacco (CRST) to Assess Changes in Use Behaviors, Product Marketing, and the Marketplace (U01 Clinical Trial Not Allowed) LOI due: March 20, 2022 (LOI not required but highly encouraged); Application due: May 8, 2022, 5 p.m. PT

CancerNCI Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) and Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) LOI due: March 22, 2022 (LOI not required but highly encouraged); Application due: April 22, 2022, 5 p.m. PT

Cancer NCI Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) LOI due: March 22, 2021 (LOI not required but highly encouraged); Application due: April 22, 2022, 5 p.m. PT

April 2022

MultidisciplinaryMultiple NIH Organizations Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional) and Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional) Application due: April 18, 2022, 5 p.m. PT

MultidisciplinaryNIDDK High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional) LOI due: April 20, 2022 (six weeks before application deadline) (LOI not required but highly encouraged); Application due: June 1, 2022, 5 p.m. PT

May 2022

Cancer NCI Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) LOI due: May 7, 2022 (LOI not required but highly encouraged); Application due: June 7, 2022, 5 p.m. PT

MultidisciplinaryNHLBI Notice of Special Interest (NOSI): Examining Effects of HIV Pre-Exposure Prophylaxis (PrEP) on Heart, Lung, Blood, and Sleep Function Deadline: Open from May 7, 2022 through May 8, 2025

MultidisciplinaryNIGMS National and Regional Resources (R24 – Clinical Trial Not Allowed) LOI due: May 14, 2022 (LOI not required but highly encouraged); Application due: June 14, 2022, 5 p.m. PT

Mental Health NIMH Pilot Practice-based Research for Primary Care Suicide Prevention (R34 Clinical Trial Optional) LOI due: May 20, 2022 (LOI not required but highly encouraged); Application due: June 21, 2022, 5 p.m. PT

June 2022

Multidisciplinary Multiple NIH Organizations Risk and Protective Factors of Family Health and Family Level Interventions (R01 – Clinical Trial Optional) Deadline: June 5, 2022, 5 p.m. PT

Substance Use NIAAA Notice of Special Interest (NOSI): Epidemiology and Prevention of Alcohol Misuse in Understudied Young Adult Populations; Military, Workforce, and Community College Deadline: Open from June 5, 2022 through Sept. 8, 2025

Multidisciplinary Multiple NIH Organizations Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required), (R01 Clinical Trial Required) and (R01 Clinical Trials Not Allowed) Deadline: June 21, 2022, 5 p.m. PT

Open

NeuroscienceDoD Amyotrophic Lateral Sclerosis Research Program Awards Deadline: Not announced yet; will be posted here again when deadline is announced

Cancer DoD Breast Cancer Research Program Awards Deadline: Not announced yet; will be posted here again when deadline is announced

NeuroscienceDoD Epilepsy Research Program Awards Deadline: Not announced yet; will be posted here again when deadline is announced

Cancer DoD Ovarian Cancer Research Program Awards Deadline: Not announced yet; will be posted here again when deadline is announced

Multidisciplinary DoD Tuberous Sclerosis Complex Research Program Awards Deadline: Not announced yet; will be posted here again when deadline is announced

Substance Abuse NIAAA NOSI: Advances in Research for the Treatment, Services, and Recovery of Alcohol Use Disorder Deadline: Open through Sept. 8, 2023

HIV/AIDS NIMH Notice of Special Interest: Advancing Health Communication Research on HIV Prevention, Treatment and Cure Deadline: Open through March 1, 2024

Multidisciplinary NHLBI and NIEHS NOSI: Stimulating Intervention Research to Reduce Cardiopulmonary Impacts of Particulate Matter in Air Pollution among High-Risk Populations Deadline: Open through Sept. 7, 2025

Genomics  NHGRI Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed) Applications are accepted by continuous receipt

Biology NSF Biophotonics Applications accepted anytime

Biology NSF Cellular and Biochemical Engineering Applications accepted anytime

Biology  NSF Dear Colleague Letter: Conferences for Building Computational Literacy in Biological Sciences Deadline: Open

MultidisciplinaryNSF Dear Colleague Letter: Pilot Projects for Cyberinfrastructure Centers of Excellence Deadline: Rolling

Biology NSF Division of Integrative Organismal Systems Core Programs Applications accepted anytime

Biology NSF Division of Molecular and Cellular Biosciences: Investigator-initiated research projects (MCB) Deadline: Open

Multidisciplinary NSF Enabling Discovery through GEnomic Tools (EDGE) Deadline: Open

Biology NSF Infrastructure Innovation for Biological Research (Innovation) Deadline: Open

Biology NSF Transitions to Excellence in Molecular and Cellular Biosciences Research (Transitions) Deadline: Open

Private 

January 2022

Sports Medicine American College of Sports Medicine Carl V. Gisolfi Memorial Fund Deadline: Jan. 14, 2022, 8:59 p.m. PT

Sports Medicine American College of Sports Medicine Clinical Sports Medicine Endowment Deadline: Jan. 14, 2022, 8:59 p.m. PT

Rheumatology Arthritis National Research Foundation Research Grants Deadline: Jan. 14, 2022

Immunology Johnson & Johnson Innovation Immunology Innovations QuickFire Challenge Deadline: Jan. 14, 2022

NeuroscienceAmerican Epilepsy Society Postdoctoral Research Fellowships Deadline: Jan. 15, 2022

NeuroscienceWhitehall Foundation Research Grants and Grants-in-Aid LOI due: Jan. 15, 2022; Application due: June 1, 2022

MultidisciplinaryJA Community Foundation Endeavor Awards LOI due: Jan. 20, 2022; Full proposal due: Feb. 20, 2022

Dermatology National Psoriasis Foundation Psoriatic Disease Research Fellowships Deadline: Jan. 21, 2022, 5 p.m. PT

Dermatology National Psoriasis Foundation Research Funding Deadline: Jan. 21, 2022, 5 p.m. PT

Pediatrics American Academy of Pediatrics CATCH Planning, Implementation, and Resident Grants Deadline: Jan. 24, 2022, 9:59 p.m. PT

Dermatology Pfizer 2022 Fellowship for Inflammatory Dermatological Diseases Deadline: Jan. 24, 2022, 8:59 p.m. PT

GastroenterologyPfizer 2022 Inflammatory Bowel Disease (IBD) Fellowship Deadline: Jan. 27, 2022, 8:59 p.m. PT

Multidisciplinary L’Oréal USA For Women in Science Fellowship Deadline: Jan. 28, 2022, 8:59 p.m. PT

Neuroscience Parkinson’s Foundation Community Grants Deadline: Jan. 28, 2022, 8:59 p.m. PT

MultidisciplinaryAmerican Psychological Foundation Alice F. Chang Cancer Wellness Grant Deadline: Jan. 31, 2022

Psychology American Psychological Foundation Div. 37 Diane J. Willis Early Career Award Deadline: Jan. 31, 2022

CancerEvansMDS Discovery Research Grants LOI due: Jan. 31, 2022; Full application due: April 2022
This organization is on the President’s List; submit a notice of intent form before applying

Cancer EvansMDS Young Investigator Awards Deadline: Jan. 31, 2022
This organization is on the President’s List; submit a notice of intent form before applying

February 2022

Neuroscience FRAXA Research Foundation Fellowships Deadline: Feb. 1, 2022, 8:59 p.m. PT

Cancer Jane Coffin Childs Memorial Fund for Medical Research Postdoctoral Fellowship Deadline: Feb. 1, 2022

Physical Therapy Massage Therapy Foundation Research Support Grant Deadline: Feb. 1, 2022, 9:59 p.m. PT

Multidisciplinary PhRMA Foundation Health Outcomes Research and Translational Medicine Grants Deadline: Feb. 1, 2022, 8:59 p.m. PT

Cancer Sarcoma Foundation of America 2022 Research Grants Deadline: Feb. 1, 2022, 2 p.m. PT

Nursing National League for Nursing Nursing Education Research Grants Deadline: Feb. 3, 2022

NeuroscienceAlzheimer’s Drug Discovery Foundation Core Funding Programs LOI due: Feb. 4, 2022, 2 p.m. PT; Applications due: April 8, 2022, 2 p.m. PT
This organization is on the President’s List; submit a notice of intent form before applying

Emergency Medicine Emergency Medicine Foundation Health Disparities Research Grant Deadline: Feb. 4, 2022

Emergency Medicine Emergency Medicine Foundation and Society for Academic Emergency Medicine Medical Student Research Grant Deadline: Feb. 4, 2022

Nursing Johnson & Johnson Innovation Nurse-led Tech QuickFire Challenge Deadline: Feb. 4, 2022

Cancer Leukemia Research Foundation Hollis Brownstein Research Grants Program LOI due: Feb. 4, 2022, 10 a.m. PT; Applications due: April 4, 2022, 10 a.m. PT

Neuroscience Parkinson’s Foundation Movement Disorders Fellowship Deadline: Feb. 4, 2022

Neuroscience Organization for Autism Research Graduate Research Grant Competition Deadline: Feb. 7, 2022, 8:59 p.m. PT

Gastroenterology Pfizer 2022 IBD Competitive Grant Program Deadline: Feb. 7, 2022, 8:59 p.m. PT

Surgery American Shoulder and Elbow Surgeons Foundation Research Grant Deadline: Feb. 8, 2022

Rheumatology Pfizer 2022 Rheumatology Competitive Grant Program Deadline: Feb. 8, 2022, 8:59 p.m. PT

Cancer American Society for Radiation Oncology Minority Summer Fellowship Award Deadline: Feb. 11, 2022

MultidisciplinaryDanone North America Gut Microbiome, Yogurt and Probiotics Fellowship Grant Deadline: Feb. 14, 2022

Nephrology National Kidney Foundation Young Investigator Research Grant Deadline: Feb. 14, 2022

Psychology American Psychological Foundation Trauma Psychology Grant Deadline: Feb. 15, 2022

Rheumatology Pfizer 2022 Rheumatology Fellowship Deadline: Feb. 15, 2022, 8:59 p.m. PT

Cardiology American Heart Association Research Grants Deadline: Deadlines go through Feb. 16, 2022, 1 p.m. PT

Pulmonology Cystic Fibrosis Foundation Funding Opportunities Deadline: All applications due Feb. 16, 2022, 2 p.m. PT, except First and Second Year Fellowships, due March 2, 2022, 2 p.m. PT

Dermatology Pfizer Inflammatory and Immune-Mediated Dermatologic Disorders Research RFP: Early Career Investigators Deadline: Feb. 24, 2022, 8:59 p.m. PT

Audiology Hearing Health Foundation Emerging Research Grants Deadline: Feb. 25, 2022

Sexual Health Sexual Medicine Society of North America Young Clinicians Research Grant Deadline: Feb. 28, 2022

Neuroscience Simons Foundation Autism Research Initiative Bridge to Independence Award Deadline: Feb. 28, 2022, 2 p.m. PT
This organization is on the President’s List; submit a notice of intent form before applying

March 2022

Cardiology Abbott Fellowship Program Grants Deadline: March 1, 2021

Cancer Mark Foundation Endeavor Awards Deadline: LOI due: March 1, 2022; LOI due: Aug. 2, 2022, 2 p.m. PT
This organization is on the President’s List; submit a notice of intent form before applying

Physical Therapy Massage Therapy Foundation Research Award LOI due: March 1, 2022, 9:59 p.m. PT; Full application due: Aug. 1, 2022, 9:59 p.m. PT

Hematology Pfizer 2022 Global Hemophilia ASPIRE Deadline: March 1, 2022, 8:59 p.m. PT

Open

HIV/AIDS amfAR Target Grants Deadline: Rolling

Substance Abuse Charles Koch Foundation Substance Abuse Research Grants Deadline: Rolling

NeuroscienceCure SMA Newborn Screening for Spinal Muscular Atrophy Program Deadline: Rolling

Pulmonology Cystic Fibrosis Foundation Path to a Cure: Industry Award Program Deadline: Rolling, but LOI required

Multidisciplinary Robert Wood Johnson Foundation Evidence for Action: Innovative Research to Advance Racial Equity Deadline: Rolling; applicant webinar on Oct. 13, 2021, 10 a.m. PT
This organization is on the President’s List; submit a notice of intent form before applying

Multidisciplinary Robert Wood Johnson Foundation Evidence for Action: Investigator-Initiated Research to Build a Culture of Health Deadline: Open
This organization is on the President’s List; submit a notice of intent form before applying

Multidisciplinary Robert Wood Johnson Foundation Pioneering Ideas: Exploring the Future to Build a Culture of Health Deadline: Rolling
This organization is on the President’s List; submit a notice of intent form before applying

Neuroscience  SFARI Supplement to Enhance Equity and Diversity (SEED) Deadline: Rolling
This organization is on the President’s List; submit a notice of intent form before applying

Leave a Reply